Shalby Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Attractively valued vs sector (P/E 36.7x vs industry 50.2x)
- Near 52-week low — potential value zone (₹111)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SHALBY · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 74.12% | 74.24% | 74.25% | 74.25% | 74.27% | 74.27% |
| FII | 4.62% | 4.88% | 5.35% | 5.37% | 4.65% | 4.54% |
| DII | — | — | 0.06% | 0.09% | 0.14% | 0.18% |
| Public | 20.42% | 20.13% | 19.65% | 19.59% | 20.26% | 20.33% |
| Others | 0.83% | 0.76% | 0.70% | 0.69% | 0.69% | 0.69% |
Latest News
All newsShalby to discuss Q2FY2027 earnings in investor call
*Shalby to discuss Q2FY2027 earnings in investor call*. Shalby Limited is scheduled to host an analyst and institutional investor meet to review its Q2FY2027 financial performance. The con-call will provide insights into revenue trends, operating margins, and future guidance. Investors will watch for updates on occupancy rates and elective surgery volumes, which are key to near-term growth. 📊 *STOCKS:* $SHALBY | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Earnings
Shalby informs shareholders about AGM and annual report access
*Shalby informs shareholders about AGM and annual report access*. Shalby Limited has notified shareholders without registered email IDs to access the **Annual Report FY 2025-26** and **Notice of 22nd AGM** via a specified web link. This is a routine corporate communication ahead of the annual general meeting. No financial or operational updates were disclosed. 📊 *STOCKS:* $SHALBY | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #AGM
Shalby shares unchanged after investor meet updates
*Shalby shares unchanged after investor meet updates.* The company shared recording of its recent Analyst/Institutional Investor meet. No **new financial guidance** or major announcements were disclosed. The update primarily covered business performance and strategy. 📊 *STOCKS:* $SHALBY | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorMeet